Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.

导出 LinkOut

翻译打印收藏纠错

作者： Abbas Ali,Qayyum ^[1] ; Bas,van Klarenbosch ^[2] ; Sabina,Frljak ^[3] ; Andraz,Cerar ^[3] ; Gregor,Poglajen ^[3] ; Denise,Traxler-Weidenauer ^[4] ; Pawel,Nadrowski ^[5] ; Christina,Paitazoglou ^[6] ; Bojan,Vrtovec ^[3] ; Martin W,Bergmann ^[6] ; Steven A J,Chamuleau ^[2] ; Wojtek,Wojakowski ^[5] ; Mariann,Gyöngyösi ^[4] ; Adriaan,Kraaijeveld ^[2] ; Kristian Schultz,Hansen ^[7] ; Karsten,Vrangbaek ^[7] ; Erik,Jørgensen ^[1] ; Steffen,Helqvist ^[1] ; Francis Richard,Joshi ^[1] ; Ellen Mønsted,Johansen ^[1] ; Bjarke,Follin ^[1] ; Morten,Juhl ^[1] ; Lisbeth Drozd,Højgaard ^[1] ; Anders Bruun,Mathiasen ^[1] ; Annette,Ekblond ^[1] ; Mandana,Haack-Sørensen ^[1] ; Jens,Kastrup ^[1] ; SCIENCE Investigators

作者单位： Department of Cardiology and Cardiology Stem Cell Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. ^[1] Department of Cardiology and Regenerative Medicine Center, University Medical Center Utrecht, Utrecht, The Netherlands. ^[2] Advanced Heart Failure and Transplantation Center, University Medical Centre Ljubljana, Ljubljana, Slovenia. ^[3] Department of Cardiology, Medical University of Vienna, Vienna, Austria. ^[4] Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland. ^[5] Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany. ^[6] Faculty of Social Sciences and the Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. ^[7]

关键词 Adipose tissue derived-mesenchymal stromal cells Allogeneic therapy Clinical trial Heart failure Ischaemic cardiomyopathy Stem cells